Ryan David Lake - 12 Nov 2021 Form 4 Insider Report for Recro Pharma, Inc.

Role
Chief Financial Officer
Signature
By: Ryan D. Lake
Issuer symbol
N/A
Transactions as of
12 Nov 2021
Net transactions value
+$1,997
Form type
4
Filing time
16 Nov 2021, 05:05:17 UTC
Previous filing
13 Jul 2021
Next filing
17 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Purchase $1,916 +1,162 +0.31% $1.65 374,335 12 Nov 2021 Direct
transaction SCTL Common Stock Purchase $80.9 +50 +0.01% $1.62 374,385 12 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.